Reid Huber is a Partner at Third Rock Ventures, where he focuses on company formation, development, and strategy for the firm’s portfolio companies. He invests in life sciences and biotechnology, including pharmaceutical R&D and drug discovery, across stages from Seed through Series C in the United States, with a focus on the Greater Boston area. He is based in Boston and serves on the boards of Merida Biosciences, Synnovation Therapeutics, Rapport Therapeutics, MOMA Therapeutics, and Terremoto Biosciences. He has invested in companies including Synnovation Therapeutics, Rapport Therapeutics, MOMA Therapeutics, Terremoto Biosciences, and Asher Biotherapeutics. Before Third Rock Ventures, he was Executive Vice President and Chief Scientific Officer and previously Senior Vice President of Discovery Biology at Incyte, and held scientific research roles at DuPont and Bristol-Myers Squibb. Reid studied at Washington University School of Medicine in St. Louis.
Reid Huber, Partner @ Third Rock. Profile with intro opportunities and ranking information.
Not Yet Mapped
We've created a profile for Reid Huber from Third Rock Ventures. Our ranking analysis and additional data will be available once our research is complete.
Rankings and detailed information coming soon
Network Strength
No ranking data available yet.
How to get an intro to Reid
Map your path to Reid instantly
Connect your network and Draftboard will automatically find and score the strongest paths to Reid
That's it. Draftboard does the rest.
Rankings based on connection strength analysis - we ONLY show aggregate data, never specific connection data.